Clinical trials: Hyperkalemic Periodic Paralysis
Hyperkalemic Periodic Paralysis, Hypokalemic Periodic Paralysis
Hyper- and Hypokalemic Periodic Paralysis Study
The purpose of this study is to compare Dichlorphenamide with placebo (an inactive substance) for prevention of episodes and for improvement of strength in hyperkalemic (HYP) and hypokalemic (HOP) periodic paralysis.
- Trial name
- HYP-HOP (NCT00494507)
- Testing
- Dichlorphenamide (double-blind), Dichlorphenamide (open-label)
- Where
- 12 sites in United States, Italy and 1 more
- Volunteers
- 71 people
- Sponsor
- University of Rochester